BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, it was demonstrated that CD25hi Treg suppress effector responses (proliferation, IFN-γ and granzyme B production) of T cells specific for LAAs, such as HLA-A3 restricted BCR-ABL peptide [171].